Annual Epidemiological Report Chlamydia for 2014

This edition of the Annual Report gives special attention to vaccine-preventable diseases and immunisation programmesin the European Union (EU) and European Economic Area (EEA) countries. This edition was revised January and June 2010 and has authority over the print edition.

Lymphogranuloma venereum (LGV) is a systemic STI caused by Chlamydia trachomatis serovars L1, L2, or L3. In 2016, 2 043 cases of LGV were reported in 22 countries.

In 2016, 37 congenital syphilis cases were reported in 23 EU/EEA Member States, at a crude rate of 1.1 cases per 100 000 live births.p

In 2017, 33 189 confirmed syphilis cases were reported in 28 EU/EEA Member States. Reported syphilis rates were nine times higher in men than in women and peaked among 25–34-year-old men. Two-thirds of syphilis cases with information on transmission category were reported in men who have sex with men (MSM). The trend in syphilis rates has been on the rise since 2011, particularly among men, mainly due to an increase in the number of cases among MSM. The slight increase of syphilis rates among women, seen already in 2016, continued in 2017.

75 349 cases of gonorrhoea were reported by 27 EU/EEA Member States for 2016.

A total of 100 673 confirmed cases of gonorrhoea were reported by 28 EU/EEA Member States for 2018.

70 056 cases of gonorrhoea were reported by 28 EU/EEA Member States for 2015.

In 2016, 29 365 syphilis cases were reported in 28 EU/EEA Member States; the incidence rate for 2016 was 6.1 cases per 100 000 population.

In 2017, 30 EU/EEA Member States reported 26 907 cases of hepatitis B virus (HBV) infection. Excluding the five countries that only reported acute cases, the number of cases, 26 262, corresponds to a crude rate of 6.7 cases per 100 000 population.